Latest News

Filters

Filter by tags: United States Russia CANDU reactor Clear all tag filters

22 news articles found

The director of the Jordan Atomic Energy Commission (JAEC) Khaled Touqan, said, looking forward to the next 10 years, JAEC is considering small reactors. It is looking at various possibilities including designs from Russia, Korea, France, and the UK, trying to determine the optimal technical specifications and how to adapt such reactors to the Jordanian environment, Touqan explained. He noted the potential use of small nuclear reactors for water desalination as well as power production.

Source: NEI Magazine
Date: Saturday, 29 April 2023
Original article: neimagazine.com/news/newsjordan-considers-floating-npps-10798331

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Source: Nucnet
Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

The production of cobalt-60 is critical to healthcare and, with demand soaring, the challenge is to expand supply, writes Martin Comben from the International Irradiation Association.

Source: World Nuclear News
Date: Wednesday, 29 March 2023
Original article: world-nuclear-news.org/Articles/The-critical-production-of-cobalt-60-in-nuclear-re

In a wide ranging interview for the World Nuclear News podcast, Cameco CEO Tim Gitzel explained: Why the time was right for the Westinghouse deal How Russia's war with Ukraine has led to 'bifurcation' of the nuclear sector Explained Cameco's long-term strategy Looks ahead at the impact of new technologies, including SMRs How nuclear will need to play a key role in getting to net-zero

Source: World Nuclear News
Date: Wednesday, 09 November 2022
Original article: world-nuclear-news.org/Articles/In-Quotes-Cameco-s-Tim-Gitzel-WNN-podcast-on-nucle

Cameco Corporation and Brookfield Renewable Partners, together with its institutional partners (the consortium), are forming a strategic partnership to acquire Westinghouse Electric Company. Brookfield Renewable, with its institutional partners, will own a 51% interest in Westinghouse and Cameco will own 49%.

Source: NEI Magazine
Date: Friday, 14 October 2022
Original article: neimagazine.com/news/newscameco-and-brookfield-renewable-to-acquire-westinghouse-10084610

Source: NEI Magazine
Date: Thursday, 14 July 2022
Original article: neimagazine.com/news/newsfrom-candu-vision-to-smr-mission-9847712

A Memorandum of Understanding (MoU) between Framatome and Exelon Generation will see the two companies work towards the production of cobalt-60 (Co-60) in pressurised water reactors (PWRs) for medical and industrial uses.

Source: World Nuclear News
Date: Thursday, 06 January 2022
Original article: world-nuclear-news.org/Articles/Framatome-and-Exelon-to-explore-Co-60-production

The US Department of Energy (DOE) is asking the public for its input on plans to create a new programme to assure the availability of high-assay low-enriched uranium (HALEU) fuel - needed for the demonstration and commercial deployment of advanced reactors - in the USA. Meanwhile, Centrus is working with Clean Core Thorium Energy on advanced fuel using HALEU and thorium.

Source: World Nuclear News
Date: Thursday, 16 December 2021
Original article: world-nuclear-news.org/Articles/USA-builds-HALEU-supply-chain

Iran’s parliament on 2 November approved a bill requiring the Atomic Energy Organisation of Iran (AEOI) to produce at least 120kg of 20% enriched uranium a year at its Fordow nuclear facility.

Source: NEI Magazine
Date: Friday, 06 November 2020
Original article: neimagazine.com/news/newsiranian-parliament-approve-bill-specifying-increase-uranium-enrichment-8347157

The International Thermonuclear Experimental Reactor (ITER) Organisation on 15 October signed a Cooperation Agreement with the Canadian government, which sets out terms for the transfer of Canadian-supplied nuclear material (tritium), and tritium-related equipment and technology.

Source: NEI Magazine
Date: Friday, 23 October 2020
Original article: neimagazine.com/news/newscanada-returns-to-iter-8195013

Load more news